Oncology Flashcards
Doxorubicin
Anthracycline
Intercalation
Free radical damage
Interferes with topoisomerase II after it cleaves ligates DNA
I: ALL, AML, Osteosarcoma, Ewing Sarcoma, Hodgkin Lymhoma, NHL, Neuroblastolma
Cardiac damage Arrythmia Radiation dermatitis Red Urine Myelosupression Conjunctivitis Nausea Vomiting
Vincristine
vinca alkaloid
ALL, NHL, Hodgkin lymphoma, Wilms, Ewing Sarcoma, Neuroblastoma, Rhabdomyosarcoma
Peripheral neuropathy
Jaw pain
(Cellulilits, Constipation, Illeus, SiADH, Seizures, Ptosis, Minimal myelosuppression)
Cyclophosphamide
Alkylation agent
myeloid suppression
Etoposide
Topoisomerase inhibitor (Topoisomerase mediated strand breaks to DNA)
I: ALL, NHL, Germ Cell tumour, Ewing Sarcoma
ADR: Myelosuppresion, Secondary leukaemia, Nausea, Vomiting
Ifosfamide
Fosfamide = Phosphamide
Alkylating agent
Alkylates Guanine - to inhibit DNA synthesis
NHL
Wilms
Soft tissue sarcoma
ADR: Pulmonary fibrosis Haemorrhagic Cystists Myelosuppresion SiADH CNS dysfunction Cardiac toxic Anaphylasis
Actinomycin-d
Xxx
Most common bone cancers?
Osteosarcoma
Long bones
Anywhere on bone incl metaphysis
Ewing’s Sarcoma
Diaphysis (middle) of long bone
Pelvis
Vertebral
Busulfan
Lung damage
Used in high risk or relapsed Ewing’s Sarcoma
Most common soft tissue sarcoma
Rhabdomyosarcoma
Risk increased with LIfreu
Mostly kids under 6
Embroyonal (tests/vagina)
Vs non embroyonal (Alveolar)
Particular mutation in FOXO1 partner PAX3 or PAX7
Detect with breakaway FISH or RTPCR
Head and neck 40%
Genitourinary 20%
Presents with mass and local effects: Proptosis PV discharge CN Palsy Urinary retention
Imaging locally
Regional LN
LUNGS
Bone marrrow (but super rare)
BIOPSY OF PRIMARY TUMOUR AND SENTINEL LN
Favourable <5cm and age 1-10
unfavourable if parameningeal, extremities, bladder
Most treatment is RADIATION 54Gy
Surgery if resectable
Chemo is essential
VAC Vincristine Actinimycin Cyclophospanide
IFOSFAMIDE in place of Cyclophosphamide
DOXORUBICIN IF METASTATIC
Oral subgroups of ViNorelbine/cyclophosphamide
temSirolimus (mTor inhibitor)
Outcomes for SARCOMAS?
localised 65-75%
Metastatic 20-30%
How to treat Leukaemia
Induction
Pre treatment with steroid and IT methotrexate
Favourable:
3 drugs
Dexamethasone Asparginase vincristinr
4 drugs (for includes HR or TCell ALL) Doxorubicin aka anthracycline
Then CNS PROPHYLAXSIS
IT METHOTREXATE (Or other IT CHEMO)
High Dose Methotrexate instead of radiation unless super high risk
maintainance with
6MP
Cancer emergency’s
Leuhostasis - lung and brain
Big cells. Lots of them. AML
Haemorrhage
give platelets and urgent cytoreduction (steroids ALL, hydroxyurea AML)
Tumour lysis syndrome
ELEVATED LDH
Rx allopurional and alkaloid hyperhyrdation
If high risk rasburicase (Lyse uric acid) and hyperhydration
Leukaemia prognosis
ALL. - 90% cure
AGE 1-5
Good early response (MRD)
AML - 60% survival
Imatinib?
Gleevac
TKI antidote to philadelphia protein - a fusion protein
Revolutionised rx of
Common CN lesion for brain tumour
CN 6 - Double vision and unable to adduct- owing to long course of CN6
Rapidly progress to CN7 given location - Facial droop/smile asymmetry
Most common site of brain tumours
<1 - Supratentorial
>1 Infratentorial
Infratentorial - 1-11 >60% - medullablastoma/ependymosa/brainstem in posterior fossa
Older >11 - any location
What sort of brain tumours spread locally/metastatically
Gliomas/Gliomatous only local spread – May be able to spare CNS prophylaxsis radiation and only give local radio if low grade
Embryonal (aka medulloblastoma or PNET) - craniospinal radiation in addition to focal to cover metastatic spread
How frequent is cancer?
Annual incidence ~ 1:5000
Cumulative risk to age 20 ~1:300
Aspariginase
Depletion of L-Aspariginase
Indications: ALL, AML
ADR: Allergic Reaction PANCREATITIS
Hyperglycaemia
Platelet dysfunction/coagul\opathy
Encephalopathy